3C-TFE

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

3C-TFE, also known as 4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyamphetamine or as α-methyltrifluoroescaline (3C-trifluoroescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA; 3C-M). It is a trifluorinated derivative of 3C-E. The drug's dose is 30 mg and its duration is approximately 15 hours. It shows weak but significant affinity for the serotonin 5-HT 2A and 5-HT 2C receptors (K i = 1,825 nM and 1,659 nM, respectively).

3C-TFE was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of a number of 3C drugs was studied in 2021, but 3C-TFE was not one of the included compounds. It is a controlled substance in Canada as an analogue of amphetamine.

3C-TFE, also known as 4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyamphetamine or as α-methyltrifluoroescaline (3C-trifluoroescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA; 3C-M). It is a trifluorinated derivative of 3C-E. The drug's dose is 30 mg and its duration is approximately 15 hours. It shows weak but significant affinity for the serotonin 5-HT 2A and 5-HT 2C receptors (K i = 1,825 nM and 1,659 nM, respectively).

3C-TFE was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of a number of 3C drugs was studied in 2021, but 3C-TFE was not one of the included compounds. It is a controlled substance in Canada as an analogue of amphetamine.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1371210287 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.